Holen Sie sich die Stockscreener-App
105.88
0.93%
-0.99
Schlusskurs vom Vortag:
$106.87
Offen:
$106.05
24-Stunden-Volumen:
389.11K
Relative Volume:
0.28
Marktkapitalisierung:
$20.90B
Einnahmen:
$7.60B
Nettoeinkommen (Verlust:
$1.08B
KGV:
43.93
EPS:
2.41
Netto-Cashflow:
$1.26B
1W Leistung:
-0.88%
1M Leistung:
-5.55%
6M Leistung:
-2.45%
1J Leistung:
-13.00%
1-Tages-Spanne:
$104.65
$106.35
1-Wochen-Bereich:
$104.65
$108.12
52-Wochen-Spanne:
$101.47
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Vergleichen Sie ZBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
105.84 | 20.90B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
113.09 | 196.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
362.14 | 137.28B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
89.96 | 131.67B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
79.69 | 101.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.67 | 43.76B | 6.60B | 4.16B | 490.10M | 6.93 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
ZIMMER BIOMET HOLDINGS, INC. - Marketscreener.com
Zimmer Biomet: The Valuation Discount Is Not Justified - Yahoo Finance
Biomet Hip Lawsuit Filed Over Defective M2A Metal-on-Metal Implant - AboutLawsuits.com
ZBH Stock to Benefit From Global Expansion Despite Macro Issues - Yahoo Finance
Zimmer Biomet Holdings (NYSE:ZBH) Could Be A Buy For Its Upcoming Dividend - Simply Wall St
Zimmer Biomet Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Simply Wall St
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Kilgore News Herald
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024 - The Eastern Progress Online
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthca - GuruFocus.com
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
How Is Zimmer Biomet Holdings' Stock Performance Compared to Other Medical Device Stocks? - MSN
Zimmer Biomet receives FDA 510(k) clearance for stemless total shoulder replacement system - Healio
Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zimmer Biomet price target raised to $118 from $117 at Truist - Yahoo Finance
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024 - The Malaysian Reserve
Total Wrist Replacement Market Top PlayersZimmer Biomet, - openPR
Zimmer Biomet sets quarterly dividend for Q4 2024 By Investing.com - Investing.com Australia
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zimmer Biomet (NYSE:ZBH) Given New $118.00 Price Target at Truist Financial - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Declares Quarterly Dividend of $0.24 - MarketBeat
Zimmer Biomet Holdings (NYSE:ZBH) shareholders have endured a 23% loss from investing in the stock five years ago - Yahoo Finance
Zimmer Biomet Holdings, Inc. Announces Quarterly Cash Dividend for Fourth Quarter of 2024, Payable on or About January 31, 2025 - Marketscreener.com
Zimmer Biomet sets quarterly dividend for Q4 2024 - Investing.com India
Spine Surgery Devices Market to See Booming Growth 2024-2031 | - openPR
JP Morgan Upgrades Zimmer Biomet Holdings (ZBH) - MSN
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
JPMorgan Chase & Co. Upgrades Zimmer Biomet (NYSE:ZBH) to Overweight - MarketBeat
Orthopaedic Implants Market Research with Growth Forecasts - GlobeNewswire
Orthopaedic Implants Market Research with Growth Forecasts to 2029: Industry Dominated by Stryker Corporation, Zimmer Biomet, Johnson & Johnson MedTech, Smith+Nephew, and B. Braun - Yahoo Finance UK
Franklin Resources Inc. Cuts Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc. stock rises Monday, still underperforms market - MarketWatch
Zimmer receives FDA nod for stemless shoulder implant - Yahoo Finance
Zimmer Biomet’s total shoulder replacement system gains FDA 510(k) clearance - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Purchased by Toronto Dominion Bank - MarketBeat
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, growth targets - Investing.com
M&T Bank Corp Raises Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference - The Eastern Progress Online
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement - BioSpace
Zimmer Biomet wins FDA nod for stemless shoulder system - Mass Device
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Virtu Financial LLC - MarketBeat
Geode Capital Management LLC Has $524.94 Million Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Public Employees Retirement System of Ohio - MarketBeat
Verition Fund Management LLC Reduces Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Secures FDA Clearance for Revolutionary Stemless Shoulder Replacement System - StockTitan
Zimmer Biomet to Present at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences - The Eastern Progress Online
2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Stifel Financial Corp - MarketBeat
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results - The Eastern Progress Online
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):